Download PDF
CC BY-NC-ND 4.0 · Thorac Cardiovasc Surg Rep 2021; 10(01): e1-e5
DOI: 10.1055/s-0040-1721483
Case Report: Cardiac

Allegra Transcatheter Heart Valve inside a Degenerated Sutureless Aortic Bioprosthesis

Maximilian Vondran 
1   Department of Cardiac and Thoracic Vascular Surgery, University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany
2   Department of Cardiac and Vascular Surgery, Herz-Kreislauf-Zentrum, Rotenburg an der Fulda, Germany
,
Bernd Abt
3   Department of Cardiology, Herz-Kreislauf-Zentrum, Rotenburg an der Fulda, Germany
,
Holger Nef
3   Department of Cardiology, Herz-Kreislauf-Zentrum, Rotenburg an der Fulda, Germany
4   Department of Cardiology, University Hospital Giessen and Marburg, Campus Giessen, Giessen, Germany
,
Ardawan J. Rastan
1   Department of Cardiac and Thoracic Vascular Surgery, University Hospital Giessen and Marburg, Campus Marburg, Marburg, Germany
2   Department of Cardiac and Vascular Surgery, Herz-Kreislauf-Zentrum, Rotenburg an der Fulda, Germany
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

Transcatheter aortic valve-in-valve implantation (VIV) is increasingly being used to successfully treat degenerated surgical aortic valve bioprostheses (SAVs). The new self-expanding transcatheter heart valve Allegra, from New Valve Technology with its special implantation mechanism, has proven its safety and feasibility for patients with degenerated SAVs, but it has never been used in the latest-generation sutureless SAV. To the best of our knowledge, this is the first description of the successful VIV of the Allegra prosthesis into a degenerated sutureless SAV, and the procedure yielded an excellent postinterventional hemodynamic results.

Keywords

heart valve - transapical - percutaneous - reoperation - aortic valve and root - cardiology/cardiologist


Publication History

Received: 10 September 2020

Accepted: 15 October 2020

Article published online:
19 January 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Deeb GM, Chetcuti SJ, Reardon MJ. et al. 1-year results in patients undergoing transcatheter aortic valve replacement with failed surgical bioprostheses. JACC Cardiovasc Interv 2017; 10 (10) 1034-1044
    CrossrefPubMedGoogle Scholar
  • 2 Webb JG, Mack MJ, White JM. et al. Transcatheter aortic valve implantation within degenerated aortic surgical bioprostheses: Partner 2 valve-in-valve registry. J Am Coll Cardiol 2017; 69 (18) 2253-2262
    CrossrefPubMedGoogle Scholar
  • 3 Powell R, Pelletier MP, Chu MWA, Bouchard D, Melvin KN, Adams C. The perceval sutureless aortic valve: review of outcomes, complications, and future direction. Innovations (Phila) 2017; 12 (03) 155-173
    CrossrefPubMedGoogle Scholar
  • 4 Schäfer U, Butter C, Landt M. et al. Thirty-day outcomes of a novel transcatheter heart valve to treat degenerated surgical valves: The vivall multicentre, single-arm, pilot study. EuroIntervention 2019; 15 (09) e757-e763
    CrossrefPubMedGoogle Scholar
  • 5 Abdel-Wahab M, Landt M, Neumann F-J. et al. CHOICE Investigators. 5-year outcomes after tavr with balloon-expandable versus self-expanding valves: Results from the choice randomized clinical trial. JACC Cardiovasc Interv 2020; 13 (09) 1071-1082
    CrossrefPubMedGoogle Scholar
  • 6 Ochiai T, Yoon SH, Sharma R. et al. Outcomes of self-expanding vs. Balloon-expandable transcatheter heart valves for the treatment of degenerated aortic surgical bioprostheses- a propensity score-matched comparison. Circ J 2018; 82 (10) 2655-2662
    CrossrefPubMedGoogle Scholar
  • 7 Landes U, Dvir D, Schoels W. et al. Transcatheter aortic valve-in-valve implantation in degenerative rapid deployment bioprostheses. EuroIntervention 2019; 15 (01) 37-43
    CrossrefPubMedGoogle Scholar
  • 8 Alnasser S, Cheema AN, Simonato M. et al. Valve-in-Valve International Data Registry Investigators. Matched comparison of self-expanding transcatheter heart valves for the treatment of failed aortic surgical bioprosthesis: Insights from the valve-in-valve international data registry (vivid). Circ Cardiovasc Interv 2017; 10 (04) e004392
    CrossrefPubMedGoogle Scholar